New research shows brain is directly connected to the immune system
news.virginia.edu
news.virginia.edu
https://news.ycombinator.com/item?id=9647253
Full link to the original study: https://www.dropbox.com/s/2mmdmty3nxfe5u8/2015-louveau.pdf
What has not been known is the mechanism: the dogma was that the blood brain barrier would prevent immune involvement. With the discovery of this new system, that dogma remains true as explained by this impressive discovery of a special access network for the immune system.
[0] http://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(...
There have been a lot attempts at doing that (the first I recall is from the late 90's but possibly even earlier), but not many have made it into actual clinical practice. Turns out that the linkage is important, the pharmacokinetics can get complicated and getting the proper concentration in the bloodstream can be difficult. That said I've heard people are getting this kind of strategy to work more recently, particularly in oncology.
But of course, better understanding and finding an alternative method around the blood brain barrier is absolutely critical to drug development. It's a huge issue for any small molecule treatment for neurological disease, and regardless of how you conjugate or what you conjugate it to (now that we know something about it, maybe a full antibody isn't required, you could maybe get nearly the same effect with a shorter peptide), this is a breakthrough.
The first protein antibody conjugates were to couple ricin to antibodies in the late 80s. Ricin's warhead polypeptide chain conveniently has a single cysteine residue that they tried to conjugate to antibodies using disulfide exchange. Of course this was not kind to the antibodies, and the structural disruption is very likely one of the reasons this strategy failed miserably.
In general the challenge for ADC is that attaching your drug to an antibody is nontrivial, and the titer is tricky. How many of your molecule does it require to take down a cell? 100? 1,000,000? Can you deliver that number of molecules to each cell, that start reliably conjugated to a large molecule, after yield losses as a result of molecular decoupling?
Also, why haven't such bbb-crossings been seen before?
Warning: Paywall. (Your tax dollars at work!)
" In searching for T-cell gateways into and out of the meninges, we discovered functional lymphatic vessels lining the dural sinuses. These structures express all of the molecular hallmarks of lymphatic endothelial cells, are able to carry both fluid and immune cells from the cerebrospinal fluid, and are connected to the deep cervical lymph nodes."
"While performing immunohistochemistry on rabbit brain sections, we noticed a small number of neurons that were stained with only the secondary antibodies to rabbit IgG. The staining was distinctively localized in the dendrites and cytoplasm of cell bodies, in a Golgi-like staining, and was obviously different from a ubiquitous ‘background’ staining." http://www.ncbi.nlm.nih.gov/pubmed/12426046
AFAIK, that research has gone largely ignored. It could mean a lot of immunohistological results are inaccurate.
If this was VC funding mechanics or technical architecture articles, this kind of stuff wouldn't fly. So why are these self-promoting research articles the exception?
So a larger proportion of medical topic articles for non-doctors get written to be consumed by least common denominator readers. My impression is that there are fewer 'informed enthusiasts' and 'pro-sumers' on medical topics compared to, say, personal computing or photography.
So, that is why there is a strong link between the brain and the gut, and it explains why we feel so strongly our emotions in the gut.
Various sources: https://www.google.com/#q=probiotics+psychological+effects+s...
Decent source: https://skeptics.stackexchange.com/questions/17811/is-70-of-...
The clinical presentation depends on whether the antibodies end up acting as agonists or antagonists of the receptor the bacterial protein targets.
There's experimental (causative) evidence in rodents and correlations in humans.
It's still very early, no clinical data has been published.